Lead

The Ebola outbreak in the Democratic Republic of Congo has killed more than 1,700 people, according to government figures, as the World Health Organization (WHO) accelerates trials of experimental treatments and vaccines. The outbreak, caused by the rare Bundibugyo strain of the virus, has been declared the second-largest on record and the fastest growing, with cases concentrated in the eastern province of Ituri.

Coverage Comparison

Reports from Africa News, Al Jazeera, and The Guardian — World provide differing statistics, reflecting the evolving nature of the outbreak. As of Tuesday, Africa News and Al Jazeera reported 3,802 cases and 1,707 deaths, citing the latest government update. The Guardian — World, citing the DRC’s national public health institute, reported 3,973 cases and 1,801 deaths as of 4 August, with cases having topped 4,000 according to the Africa Centres for Disease Control and Prevention (Africa CDC).

All three outlets highlight that the outbreak is concentrated in Ituri province, which accounts for nearly 90% of cases, though cases have also been confirmed in five other provinces. The WHO is monitoring over 17,000 potential contacts, with nearly 80% of them being seen daily, as reported by all three sources.

The Guardian — World reports concerns that the virus may be mutating, citing Dr Jean Kaseya, director general of the Africa CDC, who said studies were planned “to check if there is no additional issue, or maybe if the virus is not mutating. Because the level of severity of this Bundibugyo outbreak is unprecedented.” Al Jazeera and Africa News do not mention this concern.

Al Jazeera emphasizes the “unprecedented speed” of trials, quoting Vasee Moorthy, acting head of the WHO’s R&D Blueprint programme, who said “years of advance planning had allowed researchers to begin testing experimental treatments much sooner than in previous outbreaks.” Africa News notes that two clinical trials for post-exposure drugs are ongoing in Ituri province, as well as two separate vaccine trials in the UK and Canada. The Guardian — World mentions the use of the antiviral remdesivir on a compassionate use basis and testing of the Ervebo vaccine in the affected province.

Key Claims

  • The outbreak has recorded 3,802 cases and 1,707 deaths as of Tuesday, according to Africa News and Al Jazeera, while The Guardian — World reports 3,973 cases and 1,801 deaths as of 4 August, with cases exceeding 4,000 per the Africa CDC.
  • The outbreak is concentrated in Ituri province, accounting for nearly 90% of cases, as reported by all three outlets.
  • The WHO is monitoring over 17,000 potential contacts, with nearly 80% seen daily, according to all three outlets.
  • There are no approved vaccines or treatments for the Bundibugyo strain, as reported by Al Jazeera and Africa News.
  • Clinical trials for experimental treatments and vaccines are ongoing, as reported by all three outlets.
  • The virus may be mutating, a claim made by The Guardian — World, citing the Africa CDC director general.
  • More than two-thirds of Ebola deaths are occurring in the community rather than in treatment centres, according to The Guardian — World, which also notes that 90% of admitted patients in an MSF treatment centre in Bunia do not appear on authorities’ lists of contacts.
  • The outbreak is the second-largest on record and the fastest growing, as reported by Al Jazeera and The Guardian — World.
The Guardian — World adds details on the response’s challenges, including insufficient contact tracing and high levels of untracked transmission. It reports that Kaseya said contact tracing was insufficient, with only 10 contacts identified per patient when about 40 would be expected.

Perspectives

WHO

The World Health Organization, through its director general Tedros Adhanom Ghebreyesus and other officials, emphasizes the need for more support and highlights the rapid advancement of clinical trials. Vasee Moorthy said trials had begun sooner than in previous outbreaks and that preclinical data was promising, but cautioned that only clinical trials would determine effectiveness.

Africa CDC

The Africa Centres for Disease Control and Prevention, through Dr Jean Kaseya, expresses concern about the virus possibly mutating and calls for a scaled-up response, including going “door to door” looking for patients. Kaseya notes that the severity of the outbreak is unprecedented and that contact tracing is insufficient.

DRC Government

The DRC’s national public health institute provides official case and death figures cited across reports, reflecting the government’s role in tracking the outbreak.